Edward J Gallaher from 533 NE 37Th Ave, Beaverton, OR 97124, age 78

Wikipedia

Cranbury (Norwalk)

view source

The property had been the estate of Edward B. Gallaher, owner (since 1917)() of the Clover Manufacturing Company on Main Avenue, which made industrial ...

Resumes

Owner At Applied System Dynamics, Llc Cindy Easton At Easton Communications

view source

Location:

Portland, Oregon Area

Industry:

Research

Experience:

Applied System Dynamics, LLC (Research industry): Owner, (-) Easton Communications (Research industry): Cindy Easton, (2000-Present)

Us Patents

Erythropoietic Stimulating Agent (Esa) Dosage Determination
view source
US Patent:

20130191097, Jul 25, 2013
Filed:

Jan 4, 2011
Appl. No.:

13/519843
Inventors:

Craig L. Hocum - Winona MN, US
James T. McCarthy - Rochester MN, US
David P. Steensma - Wellesley MA, US
David Dingli - Rochester MN, US
James L. Rogers - Rochester MN, US
Edward J. Gallaher - Hillsboro OR, US
Assignee:

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:

G06F 19/12
US Classification:

703 11
Abstract:

An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.

Erythropoietic Stimulating Agent (Esa) Dosage Determination
view source
US Patent:

20180218110, Aug 2, 2018
Filed:

Mar 22, 2018
Appl. No.:

15/928717
Inventors:

- Rochester MN, US
James T. McCarthy - Rochester MN, US
David P. Steensma - Wellesley MA, US
David Dingli - Rochester MN, US
Edward J. Gallaher - Hillsboro OR, US
James L. Rogers - Rochester MN, US
International Classification:

G06F 19/12
Abstract:

An Erythropoietic Stimulating Agent (ESA) dosing system/method determines patient-specific ESA therapies for patients affected by insufficient hemoglobin production that may benefit from ESA treatment. The ESA dosing system includes a model that represents a process by which red blood cells are produced in humans. The model may include one or more parameters, the values of which are patient-specific. The model takes into account patient-specific historical hemoglobin (Hgb) data and corresponding historical ESA dosage data to estimate the patient-specific values of the model parameters, and determines a target therapeutic dose of the ESA that may maintain the patient's Hgb within a target range.